Eisbach Bio Targets HRD Therapy to Replace PARP Inhibitors
27 Dec 2024 //
PHARMACEUTICAL TECHNOLOGY
Eisbach Bio Secures CPRIT Grant to Advance Novel Cancer Therapeutic
26 Nov 2024 //
GLOBENEWSWIRE
Eisbach Bio Doses First Patient In EIS-12656 Trial
16 Sep 2024 //
GLOBENEWSWIRE